Register Now - Every Drop Matters: Reducing Product Loss in Sterile Filtration
|Articles|October 9, 2007

Steven Galson Appointed Acting Surgeon General

Steven Galson, MD, has been appointed acting surgeon general beginning October 1, 2007.

Steven Galson, MD, has been appointed acting surgeon general beginning October 1, 2007. Galson, a Rear Admiral with the US Public Health Service, joined the FDA in April 2001 as the Center for Drug Evaluation and Research (CDER) deputy center director and was appointed director in July 2005. Janet Woodcock, MD, will become acting director at CDER until a permanent center director is found. She will retain her position as deputy commissioner and permanent chief medical officer.


Related to this article

The BioPharm Brief: A First for Streamlined Biosimilar Approval, a Head-to-Head Bispecific Trial in Wet AMD, and In Vivo KIR-CAR T
Biocon’s pertuzumab biosimilar Pebrilzo becomes the first biosimilar approved under EMA’s tailored clinical approach, Visara doses the first patient in a phase 2b trial comparing its VEGF-A/ANG-2 bispecific VIS-101 with aflibercept in wet AMD, and Verismo Therapeutics licenses Stanford’s PACK-IT technology for in vivo KIR-CAR T therapies.